Cargando…

RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form

A simple, specific and accurate reverse phase liquid chromatographic method was developed for the simultaneous determination of losartan potassium and ramipril in table dosage forms. A hypersil ODS C18, 4.6×250 mm, 5 μm column in isocratic mode, with mobile phase acetonitrile:methanol:10 mM tetra bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, K. Srinivasa, Srinivas, K.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883209/
https://www.ncbi.nlm.nih.gov/pubmed/20582199
http://dx.doi.org/10.4103/0250-474X.62243
_version_ 1782182243554295808
author Rao, K. Srinivasa
Srinivas, K.
author_facet Rao, K. Srinivasa
Srinivas, K.
author_sort Rao, K. Srinivasa
collection PubMed
description A simple, specific and accurate reverse phase liquid chromatographic method was developed for the simultaneous determination of losartan potassium and ramipril in table dosage forms. A hypersil ODS C18, 4.6×250 mm, 5 μm column in isocratic mode, with mobile phase acetonitrile:methanol:10 mM tetra butyl ammonium hydrogen sulphate in water in the ratio of 30:30:40% v/v/v was used. The flow rate was 1.0 ml/min and effluent was monitored at 210 nm. The retention times of losartan potassium and ramipril were 4.7 and 3.3 min, respectively. The linearity range for losartan potassium and ramipril were in the range of 0.04-100 μg/ml and 0.2-300 μg/ml, respectively. The proposed method was also validated and successfully applied to the estimation of losartan potassium and ramipril in combined tablet formulations.
format Text
id pubmed-2883209
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28832092010-06-25 RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form Rao, K. Srinivasa Srinivas, K. Indian J Pharm Sci Short Communication A simple, specific and accurate reverse phase liquid chromatographic method was developed for the simultaneous determination of losartan potassium and ramipril in table dosage forms. A hypersil ODS C18, 4.6×250 mm, 5 μm column in isocratic mode, with mobile phase acetonitrile:methanol:10 mM tetra butyl ammonium hydrogen sulphate in water in the ratio of 30:30:40% v/v/v was used. The flow rate was 1.0 ml/min and effluent was monitored at 210 nm. The retention times of losartan potassium and ramipril were 4.7 and 3.3 min, respectively. The linearity range for losartan potassium and ramipril were in the range of 0.04-100 μg/ml and 0.2-300 μg/ml, respectively. The proposed method was also validated and successfully applied to the estimation of losartan potassium and ramipril in combined tablet formulations. Medknow Publications 2010 /pmc/articles/PMC2883209/ /pubmed/20582199 http://dx.doi.org/10.4103/0250-474X.62243 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Rao, K. Srinivasa
Srinivas, K.
RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
title RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
title_full RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
title_fullStr RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
title_full_unstemmed RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
title_short RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
title_sort rp-hplc method for the determination of losartan potassium and ramipril in combined dosage form
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883209/
https://www.ncbi.nlm.nih.gov/pubmed/20582199
http://dx.doi.org/10.4103/0250-474X.62243
work_keys_str_mv AT raoksrinivasa rphplcmethodforthedeterminationoflosartanpotassiumandramiprilincombineddosageform
AT srinivask rphplcmethodforthedeterminationoflosartanpotassiumandramiprilincombineddosageform